Streetbeat News

Products Services

BA

Boeing shares are experiencing a decline due to reports of a six-month delay in achieving its 737 MAX production target.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 7:44 pm

NFLX

TTWO

Netflix's gaming catalog has surpassed 210 million downloads, with Rockstar's Grand Theft Auto: San Andreas leading the platform with 25.2 million downloads. This marks a significant milestone in Netflix's expansion into the gaming industry.

Portfolio Pulse from Franca Quarneti

September 10, 2024 | 7:41 pm

MSFT

Microsoft is currently presenting at the Goldman Sachs Communacopia + Technology Conference, which could provide insights into the company's future strategies and performance.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 7:31 pm

LMNR

Limoneira Company (NASDAQ:LMNR) has increased its avocado volume expectations for fiscal year 2024 by over 50%, aiming to capitalize on higher prices. The company reported significant growth in avocado revenue and plans to expand production. However, it anticipates lower prices in 2025 due to international factors.

Portfolio Pulse from Michael Juliano

September 10, 2024 | 7:07 pm

CRMD

CorMedix shares rose after the company signed a multi-year commercial supply contract for DefenCath with a healthcare company for U.S. facilities.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 7:06 pm

JNJ

KMB

The FDA is addressing safety concerns about tampons after a 2024 study found metals in them. The agency has commissioned an independent literature review and initiated an internal study to evaluate these findings.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 7:00 pm

AAPL

GOOG

GOOGL

Apple released the iPhone 16 lineup, sparking mixed reactions and a four-week low in stock prices. The new models feature upgraded chips and AI integration. Competitors like Google's Pixel 9 and Samsung's Galaxy S24 offer alternatives with similar AI features.

Portfolio Pulse from Natan Ponieman

September 10, 2024 | 6:58 pm

HRMY

Harmony Biosciences is seeing strong growth with its drug Wakix, which has increased sales and patient numbers. UBS has initiated coverage with a Buy rating and a $56 price target, citing potential growth in the narcolepsy market and recent strategic acquisitions.

Portfolio Pulse from Vandana Singh

September 10, 2024 | 6:56 pm

RLAY

Relay Therapeutics (NASDAQ:RLAY) faces a downgrade from Oppenheimer due to concerns over the efficacy of its PI3K inhibitor, RLY-2608, in a competitive market. The clinical benefit rate was 57%, but competitors may offer more selective and effective treatments. RLAY stock fell 6.94% following the news.

Portfolio Pulse from Vandana Singh

September 10, 2024 | 6:50 pm

AVSC

IWM

VTWO

Paul Eitelman from Russell Investments suggests that underperformance of the 'Magnificent 7' tech giants and a 'soft landing' for the U.S. economy could trigger a rotation into small-cap stocks. This shift could benefit ETFs like iShares Russell 2000 ETF (IWM), Vanguard Russell 2000 ETF (VTWO), and Avantis US Small Cap Equity ETF (AVSC).

Portfolio Pulse from Surbhi Jain

September 10, 2024 | 6:47 pm